Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Acitretin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA known ✓ | P19793 | 12/20 | 0.43 |
| ▸ | RARG known ✓ | P13631 | 11/20 | 0.43 |
| ▸ | RARA known ✓ | P10276 | 6/20 | 0.41 |
| ▸ | RARB known ✓ | P10826 | 6/20 | 0.41 |
| ▸ | RXRB known ✓ | P28702 | 4/20 | 0.41 |
| ▸ | RXRG known ✓ | P48443 | 4/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.89 |
| ▸ | MAPT | P10636 | 8/20 | 0.89 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.89 |
| ▸ | ABCB11 | O95342 | 2/20 | 0.89 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.89 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.89 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.66 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.66 |
| ▸ | PGR | P06401 | 2/20 | 0.66 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.66 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.66 |
| ▸ | ESR1 | P03372 | 1/20 | 0.66 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.66 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acitretin SCHEMBL29496318 | 0.94 | ALDH1A1 (1.00) | ALDH1A1MAPTSMN1; SMN2ABCB11ABCC4 | |
| Acitretin SCHEMBL2280089 | 0.94 | ALDH1A1 (1.00) | ALDH1A1MAPTSMN1; SMN2ABCB11ABCC4 | |
| Acitretin SCHEMBL5028866 | 0.94 | ALDH1A1 (1.00) | ALDH1A1MAPTSMN1; SMN2ABCB11ABCC4 | |
| Acitretin SCHEMBL3759 | 0.94 | ALDH1A1 (1.00) | ALDH1A1MAPTSMN1; SMN2ABCB11ABCC4 | |
| Acitretin SCHEMBL159360 | 0.94 | ALDH1A1 (1.00) | ALDH1A1MAPTSMN1; SMN2ABCB11ABCC4 | |
| Acitretin SCHEMBL29883491 | 0.94 | ALDH1A1 (1.00) | ALDH1A1MAPTSMN1; SMN2ABCB11ABCC4 | |
| Acitretin SCHEMBL5053805 | 0.94 | ALDH1A1 (1.00) | ALDH1A1MAPTSMN1; SMN2ABCB11ABCC4 | |
| Acitretin SCHEMBL10750446 | 0.93 | ALDH1A1 (0.98) | ALDH1A1MAPTSMN1; SMN2ABCB11ABCC4 | |
| Acitretin SCHEMBL4443721 | 0.93 | ALDH1A1 (0.98) | ALDH1A1MAPTSMN1; SMN2ABCB11ABCC4 | |
| SCHEMBL10750080 | 0.89 | ALDH1A1 (0.89) | ALDH1A1MAPTSMN1; SMN2ABCB11ABCC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0263492-B1 | RETINOIDS, THEIR PREPARATION AND USE AS PHARMACEUTICAL COMPOUNDS | F. HOFFMANN-LA ROCHE AG (CH) | 1991-03-13 | — | — | EP | claimed |
| US-4900478-A | SKIN DISORDERS | HOFFMANN-LA ROCHE INC. (US) | 1990-02-13 | — | — | US | claimed |
| US-4900478-A | SKIN DISORDERS | HOFFMANN-LA ROCHE INC. (US) | 1990-02-13 | — | — | US | disclosed |